Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$0.14 - $0.27 $1,352 - $2,609
-9,664 Reduced 16.04%
50,600 $8,000
Q3 2019

Nov 13, 2019

SELL
$0.1 - $0.29 $15,882 - $46,058
-158,824 Reduced 72.49%
60,264 $6,000
Q4 2017

Feb 15, 2018

BUY
$0.05 - $0.07 $10,954 - $15,336
219,088
219,088 $13,000

Others Institutions Holding PKTX

# of Institutions
1
Shares Held
20K
Call Options Held
0
Put Options Held
0

About ProtoKinetix, Inc.


  • Ticker PKTX
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 314,329,984
  • Market Cap $3.14M
  • Description
  • ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions. It develops AAGP to treat dry-eye diseases. It has a collabo...
More about PKTX
Track This Portfolio

Track United Bank Portfolio

Follow United Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Bank, based on Form 13F filings with the SEC.

News

Stay updated on United Bank with notifications on news.